#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Scleroderma associated digital ulcer Cutaneous T-cell lymphoma Haemophilia A without inhibitors Congenital pseudarthrosis Ischaemic stroke Granulomatosis with polyangiitis Chronic granulomatous disease Von Hippel-Lindau disease Malignant central nervous system neoplasm Hypotransferrinaemia VEXAS syndrome Peripheral primitive neuroectodermal tumour of soft tissue Philadelphia positive chronic myeloid leukaemia Atopic keratoconjunctivitis Glycogen storage disease type I More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma – Life with Disease Immunodeficiency congenital – Life with Disease Vascular malformation – Diagnostics Antisynthetase syndrome Aicardi-Goutieres syndrome – Treatment Proteus syndrome – Life with Disease Mantle cell lymphoma stage III – Diagnostics Adrenocortical carcinoma – Trials in Disease Mantle cell lymphoma – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Caspofungin Acetate DCC-3084 ARGININE GLUTAMATE Methoxyflurane Ambrosia Artemisiifolia (302) Acetic Acid, Glacial Tobramycin Lutetium (177Lu) Edotreotide Cobolimab Ro7589655 Mebendazole Azelastine Lerodalcibep Asfotase Alfa Niflumic Acid Isavuconazonium Sulfate Carbetocin Amitriptyline Glucose Monohydrate Ph. Eur. Sacituzumab Govitecan More therapies…

    Learn about Your Condition

    Ligament operation Eclampsia External cephalic version Combined immunodeficiency Lung adenocarcinoma stage III Supranuclear palsy Ehlers-Danlos syndrome Cryoglobulinaemia B-cell lymphoma refractory Rectal neoplasm Rabies Gastric cancer stage IV Neurofibromatosis BRAF gene mutation Renal transplant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune system processes

  • Study on Oral PHA-022121 for Preventing Angioedema Attacks in Patients with Hereditary Angioedema

    Not recruiting

    2 1
    Investigated Diseases:
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    • Hereditary angioedema
    Investigated Drugs:
    • (S)-N-(1-Deutero-1-(3-Chloro-5-Fluoro-2-((2-Methyl-4-(1-Methyl-1H-1,2,4-Triazol-5-Yl)Quinolin-8-Yloxy)Methyl)Phenyl)Ethyl)-2-(Difluoromethoxy)Acetamide
    Austria Bulgaria Germany Ireland Italy Poland

  • Study on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Obinutuzumab
    Czechia France Italy Poland Spain

  • Study on the Safety and Effectiveness of Human Alpha1-Proteinase Inhibitor for Preventing Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplant.

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Graft versus host disease
    Investigated Drugs:
    • Human Alpha1-Proteinase Inhibitor
    Germany Italy Spain

  • Study on Methotrexate and Metformin for Patients with Rheumatoid Arthritis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Calcium Folinate
    • Methotrexate
    • Metformin Hydrochloride
    France

  • Study on the Effects of Subcutaneous Human Immunoglobulin (Newnorm) for Patients with Primary Immunodeficiency Diseases

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Germany Hungary Italy Poland Slovakia

  • Study on the Effects of Methylprednisolone and Sodium Chloride in Patients Undergoing Surgery for Digestive Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Methylprednisolone Hydrogen Succinate
    • Sodium Chloride
    France
Previous Page
1 … 10 11 12 13 14 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!